HP and idiopathic pulmonary fibrosis: Japanese guidelines for IPF published in 2017 mentioned that the evidence was scant and suggested that patients with AE-IPF should not be treated with PMX-HP, but that this therapy might be a reasonable option in a minority of patients [45].